longcovid
A new study suggests that COVID-19 can impact cognitive function a year or more after people have contracted the virus. The study enrolled more than 140,000 participants and assessed the cognitive and memory abilities of individuals who had recovered from COVID-19 compared to those who had not been infected. Study participants were tasked with completing an online cognitive evaluation using a platform called Cognitron. The tasks were designed to identify nuanced changes to cognition such as memory, reasoning, attention, and impulsivity. “The potential long-term effects of COVID-19 on cognitive...
Euronews (English)
A COVID-19 antiviral drug has been underused in Europe with about 3.1 million courses of the medicine set to expire in the UK, Germany, Spain, Italy, and France by the end of this month. With clinical trial data showing a nearly 90 per cent reduction in the risk of severe illness, Paxlovid first came to market as a critical tool against COVID-19 at the beginning of 2022. But the UK-based global health data and analytics company Airfinity said in a report earlier this year that a few of the batches initially delivered by the drug’s manufacturer Pfizer already started expiring in July 2023, acco...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら